Canagliflozin interrupts mTOR-mediated inflammatory signaling and attenuates DMBA-induced mammary cell carcinoma in rats
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Canagliflozin interrupts mTOR-mediated inflammatory signaling and attenuates DMBA-induced mammary cell carcinoma in rats
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 155, Issue -, Pages 113675
Publisher
Elsevier BV
Online
2022-09-15
DOI
10.1016/j.biopha.2022.113675
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A review of fertility preservation in patients with breast cancer
- (2022) Nicole D. Ulrich et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Protective Effect of Crocin on Immune Checkpoint Inhibitors-Related Myocarditis Through Inhibiting NLRP3 Mediated Pyroptosis in Cardiomyocytes via NF-κB Pathway
- (2022) Hui Zhang et al. Journal of Inflammation Research
- SGLT2 inhibitor, canagliflozin, ameliorates cardiac inflammation in experimental autoimmune myocarditis
- (2022) Qi Long et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Anti-cancer effect of metformin on the metastasis and invasion of primary breast cancer cells through mediating NF-kB activity
- (2021) Guven Yenmis et al. ACTA HISTOCHEMICA
- Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
- (2021) Wei Cao et al. CHINESE MEDICAL JOURNAL
- Pancancer survival analysis of cancer hallmark genes
- (2021) Ádám Nagy et al. Scientific Reports
- Canagliflozin attenuates lipotoxicity in cardiomyocytes and protects diabetic mouse hearts by inhibiting the mTOR/HIF-1α pathway
- (2021) Pengbo Sun et al. iScience
- Brucine promotes apoptosis in cervical cancer cells ( ME ‐180) via suppression of inflammation and cell proliferation by regulating PI3K / AKT / mTOR signaling pathway
- (2021) Vidya Devanathadesikan Seshadri ENVIRONMENTAL TOXICOLOGY
- mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder
- (2021) M. Perluigi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Transcriptome Profiling and Metagenomic Analysis Help to Elucidate Interactions in an Inflammation-Associated Cancer Mouse Model
- (2021) Kazuko Sakai et al. Cancers
- SGLT2 inhibitor counteracts NLRP3 inflammasome via tubular metabolite itaconate in fibrosis kidney
- (2021) Qingqing Ke et al. FASEB JOURNAL
- Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway
- (2021) Jingyi Luo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer
- (2020) Savitha Sridharan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 25-LB: SGLT2 Inhibitor Attenuates Inflammatory Response in Diabetic Kidney Disease by Inhibiting GSDMD-Related Pyroptosis
- (2020) SHIJING REN et al. DIABETES
- Beneficial effects of combination therapy of canagliflozin and teneligliptin on diabetic polyneuropathy and β-cell volume density in spontaneously type 2 diabetic Goto-Kakizaki rats
- (2020) Danyang Guo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Diallyl trisulfide potentiates chemotherapeutic efficacy of doxorubicin in experimentally induced mammary carcinoma: Role of Notch signaling
- (2020) Nehal M. Elsherbiny et al. PATHOLOGY RESEARCH AND PRACTICE
- Sodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK/mTOR pathway
- (2020) Jun Zhou et al. BIOMEDICINE & PHARMACOTHERAPY
- PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
- (2020) Daniela Miricescu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
- (2020) Torsten O Nielsen et al. JNCI-Journal of the National Cancer Institute
- Sodium-glucose cotransporters: new targets of cancer therapy?
- (2019) Ivana Vrhovac Madunić et al. Arhiv za Higijenu Rada i Toksikologiju-Archives of Industrial Hygiene and Toxicology
- Decreased incidence of Kaposi sarcoma after kidney transplant in Italy and role of mTOR-inhibitors: 1997-2016
- (2019) Pierluca Piselli et al. INTERNATIONAL JOURNAL OF CANCER
- Canagliflozin review – safety and efficacy profile in patients with T2DM
- (2019) Haroon Jakher et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Pyranocarbazole derivatives as potent anti-cancer agents triggering tubulin polymerization stabilization induced activation of caspase-dependent apoptosis and downregulation of Akt/mTOR in breast cancer cells
- (2019) Om P.S. Patel et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Polyphenols from mango (Mangifera indica L.) modulate PI3K/AKT/mTOR-associated micro-RNAs and reduce inflammation in non-cancer and induce cell death in breast cancer cells
- (2019) Shirley H. Arbizu-Berrocal et al. Journal of Functional Foods
- The role of pyroptosis in cancer: pro-cancer or pro-“host”?
- (2019) Xiaojing Xia et al. Cell Death & Disease
- The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma
- (2019) Teruo Jojima et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- P1.14-33 Canagliflozin Inhibits Lung Cancer Survival and Enhances Its Response to Radiotherapy; Effective Blockade of mTOR Pathway, HIF1a, and Mitosis
- (2019) E. Tsakiridis et al. Journal of Thoracic Oncology
- Transcriptional regulation in model organisms: recent progress and clinical implications
- (2019) Jiaqi Tang et al. Open Biology
- Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes
- (2018) Yochai Birnbaum et al. CARDIOVASCULAR DRUGS AND THERAPY
- Vitamin D nanoemulsion enhances hepatoprotective effect of conventional vitamin D in rats fed with a high-fat diet
- (2018) Mohamed El-Sherbiny et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Sodium Glucose Cotransporter 2 Inhibition Combined With Cetuximab Significantly Reduced Tumor Size and Carcinoembryonic Antigen Level in Colon Cancer Metastatic to Liver
- (2018) Junichi Okada et al. Clinical Colorectal Cancer
- Activation of WNT/β-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations
- (2018) Ye-Lim Park et al. INTERNATIONAL JOURNAL OF CANCER
- Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes
- (2018) W. Timothy Garvey et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Mitigation of cisplatin-induced peripheral neuropathy by canagliflozin in rats
- (2018) Ahmed A. Abdelsameea et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake
- (2017) Kosuke Kaji et al. INTERNATIONAL JOURNAL OF CANCER
- Anticancer activity of salicin and fenofibrate
- (2017) Marwa Sabaa et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- The Role of Oxidative Stress Modulators in Breast Cancer
- (2017) Hande Gurer-Orhan et al. CURRENT MEDICINAL CHEMISTRY
- Inhibition of PI3K/AKT/mTOR axis disrupts oxidative stress-mediated survival of melanoma cells
- (2015) Heather G. Hambright et al. Oncotarget
- BRCA1, a ‘complex’ protein involved in the maintenance of genomic stability
- (2014) Kienan I. Savage et al. FEBS Journal
- Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes
- (2014) Sue Sha et al. PLoS One
- Targeting the Akt/mTOR pathway in Brca1-deficient cancers
- (2011) T Xiang et al. ONCOGENE
- Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond
- (2008) Vadivel Ganapathy et al. PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More